Cargando…
Effect of VEGF receptor inhibitor PTK787/ZK222548 combined with ionizing radiation on endothelial cells and tumour growth
The vascular endothelial growth factor (VEGF) receptor is a major target for anti-angiogenesis-based cancer treatment. Here we report the treatment effect of ionizing radiation in combination with the novel orally bioavailable VEGF receptor tyrosine kinase inhibitor PTK787/ZK222584 on endothelial ce...
Autores principales: | Hess, C, Vuong, V, Hegyi, I, Riesterer, O, Wood, J, Fabbro, D, Glanzmann, C, Bodis, S, Pruschy, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364010/ https://www.ncbi.nlm.nih.gov/pubmed/11747347 http://dx.doi.org/10.1054/bjoc.2001.2166 |
Ejemplares similares
-
Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials
por: Giatromanolaki, A, et al.
Publicado: (2012) -
The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib(®))
por: GAUMANN, ANDREAS K.A., et al.
Publicado: (2014) -
Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells
por: Pruschy, M, et al.
Publicado: (1999) -
Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionising radiation
por: Hostanska, K, et al.
Publicado: (2003) -
Ionizing radiation and inhibition of angiogenesis in a spontaneous mammary carcinoma and in a syngenic heterotopic allograft tumor model: a comparative study
por: Riesterer, Oliver, et al.
Publicado: (2011)